haematologic cancers

Oncology

Genetic engineering technologies allow for the creation of custom-made cells that can have transformative effects on human health.

News

Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.